Ning Xu

46PUBLICATIONS
53CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Environmental biogeochemistryHaematological tumoursPharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (46)

|Oct 26, 2026
The VCPIP1-UBE3A Deubiquitination-Ubiquitination Cascade Contributes to Castration-Resistant Prostate Cancer Progression.

|Oct 19, 2026
The NEK8/ALYREF axis promotes cisplatin resistance in bladder cancer by stabilizing CDK18 mRNA to facilitate DNA damage repair.

|Aug 27, 2026
Environmental Polyethylene Terephthalate Micro- and Nanoplastics Promote Clear Cell Renal Cell Carcinoma Progression Through Mitochondrial ROS-Associated AKT/GSK3β/β-Catenin Signaling.

|Aug 21, 2026
TRIM59 Drives Bladder Cancer Progression Through E3 Ligase-Dependent K48-Linked Degradation of PTRF.

|May 26, 2026
Design, Preclinical Evaluation, and Clinical Translation of [68Ga]Ga/[177Lu]Lu-JH120061, a Novel Radiopharmaceutical Targeting CXCR4.

|Apr 10, 2026
USP2 Attenuates Spermatogenic Cell Apoptosis Via PINK1/Parkin-Dependent Mitophagy in Varicocoele: A Functional Study.

Rui-Jie Yao, Hong Xiao, Jun-Hang Zheng

Pageof 8

Frequent Collaborators

30 joint publications

Xueyi Xue

21 joint publications

Yong Wei

8 joint publications

Qingshui Zheng

7 joint publications

Shaohao Chen